$0.01

General Information

Imugene Limited
IMU
http://www.imugene.com
Biotechnology
19
1,732

Current Price Data+

Current Price $0.011
Open $0.012
High $0.012
Low $0.011
Last Close $0.011
Volume 3861533
Price Movement - ( No change )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Stock Price

Company Overview

Business Description

Imugene Limited (IMU) is an Australian immuno-oncology focused Biopharmaceutical Company developing HER2 + ve gastric and breast cancer vaccines. The Group’s lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu.

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2015 A -2.2 -0.2 0.0% 0.0 0.0 0.0% 0.0%
2014 A -2.1 -0.3 0.0% 0.0 0.0 0.0% 0.0%
2013 A -1.6 -0.5 0.0% 0.0 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2013 A 2014 F 2015 F 2013 A 2014 F 2015 F 2013 A 2014 F 2015 F
CSL (CSL) $47,595M 0.3109 0.0443 0.2593 27.7551 26.5770 21.1041 1.55% 1.62% 2.45%
Imugene (IMU) $19M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Mesoblast (MSB) $900M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Monash IVF Group (MVF) $423M 1.8016 0.1736 0.0347 17.4103 14.8347 14.3371 3.87% 4.72% 4.89%
Sirtex Medical (SRX) $1,698M 0.6876 0.4570 0.4483 42.5395 29.1974 20.1605 0.67% 1.00% 1.45%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.90 0.00
Market 1.16 15.80 1.16 0.90
Sector 0.49 15.20 3.04 0.68

Directors

Name Position Start Date
Mr Charles Walker Chief Executive Officer, Managing Director 30 Jan 2015
Mr Paul Hopper Executive Chairman 31 Oct 2012
Dr Anton Uvarov Non-Executive Director 5 Jan 2016
Dr Axel Hoos Non-Executive Director 20 Dec 2013

Management

Name Position
Phillip Hains Chief Financial Officer,Joint Company Secretary
Justyn Stedwell Company Secretary

Substantial Shareholders

Holding Name
77,000,000 (6.55%) WebInvest Pty Ltd
69,796,875 (5.25%) Paul Hopper

Calendar of Events

Date Event
27 February 2017 Report (Interim)
29 August 2016 Report (Prelim)
29 August 2016 Report (Annual)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.